 <h1>Bismuth subcitrate potassium / metronidazole / tetracycline Side Effects</h1><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to bismuth subcitrate potassium/metronidazole/tetracycline: oral capsule</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Capsule)</p><p>Potential for CarcinogenicityMetronidazole has been shown to be carcinogenic in mice and rats. It is unknown whether metronidazole is associated with carcinogenicity in humans.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, bismuth subcitrate potassium/metronidazole/tetracycline may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking bismuth subcitrate potassium / metronidazole / tetracycline:</p><p>
<i>More common</i>
</p><ul>
<li>Belching</li>
<li>chills</li>
<li>cough</li>
<li>diarrhea</li>
<li>fever</li>
<li>general feeling of discomfort or illness</li>
<li>headache</li>
<li>heartburn</li>
<li>indigestion</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>nausea</li>
<li>runny nose</li>
<li>shivering</li>
<li>sore or dry throat</li>
<li>stomach discomfort, upset, or pain</li>
<li>sweating</li>
<li>trouble sleeping</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Back pain</li>
<li>body aches or pain</li>
<li>burning feeling in the chest or stomach</li>
<li>chest pain</li>
<li>congestion</li>
<li>dizziness</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>hoarseness</li>
<li>itching of the vagina or genital area</li>
<li>lack or loss of strength</li>
<li>lower back or side pain</li>
<li>pain during sexual intercourse</li>
<li>painful or difficult urination</li>
<li>rash with flat lesions or small raised lesions on the skin</li>
<li>sneezing</li>
<li>stuffy nose</li>
<li>tender, swollen glands in the neck</li>
<li>tenderness in the stomach area</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>trouble with swallowing</li>
<li>voice changes</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Bloated feeling</li>
<li>excess air or gas in the stomach or bowels</li>
<li>feeling of fullness</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>passing gas</li>
<li>skin rash</li>
<li>tightness of the chest</li>
<li>trouble breathing</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of bismuth subcitrate potassium / metronidazole / tetracycline may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Black or dark tongue</li>
<li>black stools</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Change in taste, or bad, unusual, or unpleasant aftertaste</li>
<li>dry mouth</li>
<li>fear or nervousness</li>
</ul><p>
<!-- end oral capsule --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bismuth subcitrate potassium / metronidazole / tetracycline: oral capsule</i></p><h3>General</h3><p>The most commonly reported side effects included abnormal feces, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abnormal feces (up to 15.6%)</p>
<p><b>Common</b> (1% to 10%): Nausea, diarrhea, abdominal pain, dyspepsia, constipation, dry mouth</p>
<p><b>Frequency not reported</b>: Flatulence, glossitis, vomiting, tongue darkening, gastritis, gastroenteritis, duodenal ulcer</p>
<p><b>Postmarketing reports</b>: Abdominal distention, eructation, flatulence, pseudomembranous colitis/Clostridium difficile colitis</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Nausea, vomiting, diarrhea, abdominal pain, constipation, furry tongue, glossitis, stomatitis, dry mouth, pancreatitis</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Nausea, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, anogenital region inflammatory lesions/inflammatory lesions with Candida overgrowth, esophagitis, esophageal ulceration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dysgeusia, dizziness</p>
<p><b>Frequency not reported</b>: Somnolence</p>
<p><b>Postmarketing reports</b>: Peripheral neuropathy</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Metallic taste, convulsive seizures, encephalopathy, aseptic meningitis, peripheral neuropathy, headache, syncope, dizziness, vertigo, incoordination, ataxia, dysarthria</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Intracranial hypertension, pseudotumor cerebri<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, abnormal laboratory tests</p>
<p><b>Frequency not reported</b>: Malaise</p>
<p><b>Postmarketing reports</b>: Fatigue, candidiasis</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Candida overgrowth, fever, weakness</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Tinnitus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal infection, urine abnormality</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Vaginal/vulvar dryness, dysuria, polyuria, incontinence, darkened urine, pelvic pressure, dyspareunia, proctitis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increase, AST increase</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Hepatotoxicity, liver failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Maculopapular rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Rash</p>
<p><b>Frequency not reported</b>: Pruritus</p>
<p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS)</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Urticaria, erythematous rash, pruritus</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Maculopapular/erythematous rash, onycholysis, nail discoloration, exfoliative dermatitis, photosensitivity, urticaria, Henoch-Schonlein purpura, systemic lupus erythematosus exacerbation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Chest pain, tachycardia</p>
<p><b>Postmarketing reports</b>: Chest discomfort</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: T-wave flattening, flushing</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Pericarditis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased appetite, increased weight</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Anorexia</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Back pain, increased blood creatinine phosphokinase, myalgia</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Joint pain</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Myasthenic syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual disturbance</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Optic neuropathy<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Reversible neutropenia/leukopenia, reversible thrombocytopenia</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, neutropenia, eosinophilia</p><h3>Renal</h3><p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Cystitis</p>
<p></p>
<p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Increased blood urea nitrogen</p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Anxiety</p>
<p></p>
<p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Confusion, irritability, depression, insomnia, decreased libido<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Angioedema, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Tetracycline:</p>
<p><b>Frequency not reported</b>: Serum sickness-like reaction<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Metronidazole:</p>
<p><b>Frequency not reported</b>: Nasal congestion<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN)." Aptalis Pharma, Birmingham, AL. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about bismuth subcitrate potassium / metronidazole / tetracycline</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>207 Reviews</li>
<li>Drug class: H. pylori eradication agents</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bismuth subcitrate, metronidazole, and tetracycline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Pylera</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Helicobacter Pylori Infection</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to bismuth subcitrate potassium / metronidazole / tetracycline: oral capsule</i></p><h3>General</h3><p>The most commonly reported side effects included abnormal feces, nausea, and diarrhea.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Abnormal feces (up to 15.6%)</p><p><b>Common</b> (1% to 10%): Nausea, diarrhea, abdominal pain, dyspepsia, constipation, dry mouth</p><p><b>Frequency not reported</b>: Flatulence, glossitis, vomiting, tongue darkening, gastritis, gastroenteritis, duodenal ulcer</p><p><b>Postmarketing reports</b>: Abdominal distention, eructation, flatulence, pseudomembranous colitis/Clostridium difficile colitis</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Nausea, vomiting, diarrhea, abdominal pain, constipation, furry tongue, glossitis, stomatitis, dry mouth, pancreatitis</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Nausea, vomiting, diarrhea, glossitis, black hairy tongue, dysphagia, enterocolitis, anogenital region inflammatory lesions/inflammatory lesions with Candida overgrowth, esophagitis, esophageal ulceration<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache, dysgeusia, dizziness</p><p><b>Frequency not reported</b>: Somnolence</p><p><b>Postmarketing reports</b>: Peripheral neuropathy</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Metallic taste, convulsive seizures, encephalopathy, aseptic meningitis, peripheral neuropathy, headache, syncope, dizziness, vertigo, incoordination, ataxia, dysarthria</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Intracranial hypertension, pseudotumor cerebri<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Asthenia, abnormal laboratory tests</p><p><b>Frequency not reported</b>: Malaise</p><p><b>Postmarketing reports</b>: Fatigue, candidiasis</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Candida overgrowth, fever, weakness</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Tinnitus<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Vaginal infection, urine abnormality</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Vaginal/vulvar dryness, dysuria, polyuria, incontinence, darkened urine, pelvic pressure, dyspareunia, proctitis<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increase, AST increase</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Hepatotoxicity, liver failure<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Maculopapular rash</p><p><b>Uncommon</b> (0.1% to 1%): Rash</p><p><b>Frequency not reported</b>: Pruritus</p><p><b>Postmarketing reports</b>: Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash with eosinophilia and systemic symptoms (DRESS)</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Urticaria, erythematous rash, pruritus</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Maculopapular/erythematous rash, onycholysis, nail discoloration, exfoliative dermatitis, photosensitivity, urticaria, Henoch-Schonlein purpura, systemic lupus erythematosus exacerbation<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Frequency not reported</b>: Chest pain, tachycardia</p><p><b>Postmarketing reports</b>: Chest discomfort</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: T-wave flattening, flushing</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Pericarditis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Frequency not reported</b>: Increased appetite, increased weight</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Anorexia</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Anorexia<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Frequency not reported</b>: Back pain, increased blood creatinine phosphokinase, myalgia</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Joint pain</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Myasthenic syndrome<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Frequency not reported</b>: Visual disturbance</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Optic neuropathy<sup>[Ref]</sup></p><h3>Hematologic</h3><p>Metronidazole:</p><p><b>Frequency not reported</b>: Reversible neutropenia/leukopenia, reversible thrombocytopenia</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, neutropenia, eosinophilia</p><h3>Renal</h3><p>Metronidazole:</p><p><b>Frequency not reported</b>: Cystitis</p><p></p><p>Tetracycline:</p><p><b>Frequency not reported</b>: Increased blood urea nitrogen</p><h3>Psychiatric</h3><p><b>Frequency not reported</b>: Anxiety</p><p></p><p>Metronidazole:</p><p><b>Frequency not reported</b>: Confusion, irritability, depression, insomnia, decreased libido<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p>Tetracycline:</p><p><b>Frequency not reported</b>: Angioedema, anaphylaxis<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Tetracycline:</p><p><b>Frequency not reported</b>: Serum sickness-like reaction<sup>[Ref]</sup></p><h3>Respiratory</h3><p>Metronidazole:</p><p><b>Frequency not reported</b>: Nasal congestion<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Pylera (bismuth subcitrate potassium/metronidazo/TCN)." Aptalis Pharma, Birmingham, AL. </p><h2>More about bismuth subcitrate potassium / metronidazole / tetracycline</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>En Espa√±ol</li>
<li>207 Reviews</li>
<li>Drug class: H. pylori eradication agents</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Bismuth subcitrate, metronidazole, and tetracycline &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Helicobacter Pylori Infection</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>